Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Conference Correspondent
ACR 2017
ASCO 2017 - Acute Myeloid Leukemia
ASCO 2017 - Chronic Lymphocytic Leukemia
ASCO 2019 - Chronic Lymphocytic Leukemia
ASCO 2020 - Lung Cancer
ASCO 2021 - GU Highlights
ASH 2016 - Chronic Lymphocytic Leukemia
ASH 2016 - Multiple Myeloma
ASH 2017 - Chronic Lymphocytic Leukemia
ASH 2018 - Chronic Lymphocytic Leukemia
ASH 2019 - Chronic Lymphocytic Leukemia
Conference Highlights ADA
Conference Highlights AHA
Conference Highlights AMCP
Conference Highlights ASCO
Conference Highlights ASH
Conference Highlights Digestive Disease Week
Conference Highlights ISPOR
Conference Highlights NCCN
Conference Highlights SABCS
IDWeek 2018
ACR 2017
,
Conference Correspondent
Long-Term Efficacy and Safety Results of SIRROUND-D Trial of Sirukumab in Patients with Active RA Despite DMARD Treatment
Play Video
ASCO 2017 - Chronic Lymphocytic Leukemia
,
Conference Correspondent
Long-Term Efficacy and Safety with Ibrutinib in Previously Treated CLL: Up to 4 Years’ Follow-Up of the RESONATE Study
Play Video
Conference Correspondent
,
ASH 2016 - Chronic Lymphocytic Leukemia
Long-Term Follow-Up of Chlorambucil plus Rituximab Combination as Frontline Therapy for Elderly and/or Unfit Patients with CLL, Including Risk Stratification
Play Video
ACR 2017
,
Conference Correspondent
Longer Duration of Response in MOBILITY Study with Sarilumab plus MTX in Patients with Active, Moderate-to-Severe RA
Play Video
Conference Correspondent
,
ASH 2016 - Chronic Lymphocytic Leukemia
Management and Outcomes of Atrial Fibrillation in Patients Receiving Ibrutinib for Hematologic Malignancies at a Single Center
Play Video
Conference Correspondent
,
ASH 2016 - Multiple Myeloma
Meta-Analysis to Compare Efficacy of Treatment Regimens for Relapsed/Refractory Multiple Myeloma Patients
Play Video
Conference Correspondent
,
ASH 2016 - Chronic Lymphocytic Leukemia
Multicenter Open-Label Phase 2 Study of Ibrutinib in Chronic Graft-versus-Host Disease (cGVHD) After Failure of Corticosteroids
Play Video
Conference Correspondent
,
ASH 2016 - Chronic Lymphocytic Leukemia
Nivolumab Combined with Ibrutinib for CLL and Richter Transformation: A Phase II Trial
Play Video
ACR 2017
,
Conference Correspondent
No Increased Cardiovascular Risk in Patients with RA Who Newly Initiated Tocilizumab versus Abatacept
Play Video
Conference Correspondent
Omadacycline for Acute Bacterial Skin and Skin Structure Infections: Integrated Analysis of Randomized Clinical Trials
Play Video
2
3
4
5
6
7
8
Page 5 of 8
Results 41 - 50 of 80